Impact of the COVID‐19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension‐specific therapy in the United States of America: An observational study

Impact of the COVID‐19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension‐specific therapy in the United States of America: An observational study

Abstract Regular expert follow‐up, risk assessment, and early therapeutic intervention minimize worsening of pulmonary arterial hypertension (PAH). COVID‐19 lockdown measures were challenging for chronic disease management. This retrospective, longitudinal analysis used US claims data (January 12, 2...

Full description

Bibliographic Details
Main Authors: Marjorie Patricia George, Hayley D. Germack, Amit Goyal, Charlotte Ward, Sean Studer, Sumeet Panjabi
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Pulmonary Circulation
Subjects:
care access
COVID‐19
pulmonary hypertension
Online Access:https://doi.org/10.1002/pul2.12283

Internet

https://doi.org/10.1002/pul2.12283

Similar Items